Astashine Capsule: A potential chemopreventive antioxidant provides promising approach in cancer therapy
Abstract
A number of substances naturally occurring in foodstuffs, particularly antioxidant compounds in plant products, have shown promise as potential chemopreventive agents. Among these phytonutrients, the yellow, orange and red carotenoid pigments have recently sparked much interest. In epidemiological studies, vegetable and fruit consumption has consistently been associated with reduced incidence of various cancers, and dietary carotenoid intake from these sources has similarly been correlated with reduced cancer risk. However, several recent large-scale intervention trials failed to find any chemopreventive effect of long-term supplementation with β-carotene, the most abundant dietary carotenoid. Several naturally occurring carotenoids other than β-carotene have exhibited anticancer activity, and are being considered further as potential chemopreventive agents. Among these carotenoids, the red pigment astaxanthin is of particular interest in health management due to its unique structural and chemical properties. Based on these facts, A Super Antioxidant ASTASHINE Capsules has been developed by R&D Centre, Lactonova Nutripharm (P) Ltd, HYDERABAD. The present paper Reviews the Role of ASTASHINE CAPSULES in the evidence for Anticarcinogenic behavior with an emphasis on the chemopreventive activities of astaxanthin.
Downloads
Published
Issue
Section
License
Rights and reuse terms depend on the individual article record. Articles accepted on or after 8 September 2026 are licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), provided appropriate credit is given, a link to the licence is supplied and changes are indicated. Earlier content remains governed by the rights and licence notice applicable to that article and is not retrospectively relicensed by this policy. Third-party material identified under a different notice is excluded from the journal licence.

